Additionally, previous research has indicated that Maresin 1 ameliorates hepatic steatosis by inhibiting ER stress mediated by the AMPK/SERCA2b pathway (Jung et al., 2018). This evidence concerns the gene PRKAA2 and fatty liver disease.